Business Context and Reporting Period
D. Boral ARC Acquisition I Corp. (BCAR) is a blank check company incorporated in the British Virgin Islands on March 20, 2025, formed to effect a business combination. This Form 10-Q covers the quarterly period ended June 30, 2026. The Company consummated its Initial Public Offering (IPO) on August 1, 2025, raising $250 million, with an additional $30 million from a partial over-allotment exercise. As of the reporting date, the Company had not commenced operations other than those related to its formation and the search for a target.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2026 | Three Months Ended June 30, 2026 |
|---|---|---|
| Net Income | $3,901,736 | $1,890,418 |
| Operating Costs | $(1,204,774) | $(673,033) |
| Interest Income (Trust Account) | $5,106,510 | $2,563,451 |
| Cash (Operating) | $41,733 (as of June 30, 2026) | N/A |
| Cash Held in Trust | $289,883,138 (as of June 30, 2026) | N/A |
| Working Capital Deficit | $(618,911) | N/A |
| Accrued Expenses | $812,530 | N/A |
| Shares Outstanding (Class A) | 29,200,000 (28M redeemable + 1.2M non-redeemable) | N/A |
| Shares Outstanding (Class B) | 12,000,000 | N/A |
Material Changes vs. Prior Period
- Profitability: The Company reported a net income of $3.9 million for the six months ended June 30, 2026, compared to a net loss of $41,420 for the period from inception (March 20, 2025) through June 30, 2025. This shift is driven entirely by interest income earned on the Trust Account, which was non-existent in the prior period.
- Liquidity: Operating cash decreased from $420,340 at December 31, 2025, to $41,733 at June 30, 2026, reflecting the burn of operating costs. Conversely, the Trust Account balance increased by approximately $5.1 million due to accrued interest.
- Liabilities: Accrued expenses increased significantly from $37,611 to $812,530, indicating a buildup of unpaid operational costs.
Outlook, Risks, and Unusual Items
- Business Combination: On January 11, 2026, the Company entered into a Merger Agreement with Exascale Labs Inc. for an aggregate consideration of $500 million. The transaction involves a reincorporation in Delaware and a merger with Exascale.
- Subsequent Event (Critical): On July 29, 2026, shareholders voted to approve the business combination. However, 95.95% of outstanding public shares (26,865,211 shares) were redeemed. Approximately $12 million remains in the Trust Account to fund the closing.
- Going Concern: Management has determined that the mandatory liquidation if a business combination is not completed raises substantial doubt about the Company's ability to continue as a going concern. The Company has a working capital deficit and relies on the completion of the merger or additional financing from the Sponsor.
- Risks: The filing notes risks related to geopolitical instability (Russia-Ukraine, Israel-Hamas conflicts) affecting global markets. Additionally, the Sponsor's indemnity obligation regarding third-party claims against the Trust Account is not secured by reserved funds.
Investor Verification Checklist
- Redemption Impact: Verify the final cash balance available to the combined entity post-redemption (approx. $12 million) and whether this satisfies the minimum cash closing condition in the Merger Agreement.
- Transaction Status: Confirm the closing date of the Exascale Labs merger, as the filing states the transaction had not closed as of August 14, 2026.
- Working Capital: Assess the Company's ability to fund operations and transaction costs given the operating cash balance of only $41,733 and a working capital deficit of $618,911.
- Share Structure: Review the post-merger capitalization, specifically the conversion of Class B founder shares and the issuance of new shares to Exascale shareholders.
- Extension Options: Determine if the Company will need to exercise its extension option (up to 21 months total) if the merger does not close immediately.